LGND

Q: What is the price of Ligand Pharmaceuticals (LGND) today?

The price of Ligand Pharmaceuticals (LGND) today is $ 198.22, with return of 72.32% compared to the last year. The price of Ligand Pharmaceuticals (LGND) started the year trading around $ 189.07 and today it is at $ 198.22. Follow the real-time price chart, the historical price of Ligand Pharmaceuticals (LGND) and international markets.

Q: When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not distribute dividends in the last year.

Q: Is Ligand Pharmaceuticals (LGND) worth it?

Currently, Ligand Pharmaceuticals (LGND) is priced at $ 198.22, with a P/E of 82.81%, representing a deviation of -9,913% from its historical average P/E. In the last year, the stock showed a variation of 72.32 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 72.32%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Ligand Pharmaceuticals (LGND) stock?

Investing in stocks of Ligand Pharmaceuticals (LGND) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Ligand Pharmaceuticals (LGND) yield today?

The yield of Ligand Pharmaceuticals (LGND) was 1.22% in the last month, 72.32% in the last year and 3.51% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Ligand Pharmaceuticals (LGND) today, the total investment would be $ 19,822.00, based on the current price of $ 198.22.If past performance were to repeat, the return on your investment would be:In 1 year: $ 34,157.27In 5 years: $ 20,517.75In 10 years: $ 38,861.03It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Ligand Pharmaceuticals Incorporated

Price

$ 198.22

return (12m)

72.32%

p/e

82.81

p/bv

4.23

DIVIDEND YIELD

0.00%

price LGND

LGND

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of LGND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.22%

3 months

4.95%

1 year

72.32%

2 years

159.28%

5 years

3.51%

10 years

96.05%

Fundamentals LGND

review the fundamentals of Ligand Pharmaceuticals shares

P/E

82.81

Sector: -3.78 Industry: -3.78

P/SALES RATIO (PSR)

16.01

Sector: -3.61 Industry: -3.61

P/BV

4.23

Sector: 2.11 Industry: 2.11

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.29%

Sector: -63.98% Industry: -63.98%

ROE

5.11%

Sector: -66.67% Industry: -66.67%

ROIC

24.83%

Sector: -1,118.64% Industry: -1,118.64%

NET MARGIN

19.34%

Sector: -41.05% Industry: -41.05%

GROSS MARGIN

94.27%

Sector: 39.22% Industry: 39.22%

OPERATING MARGIN

11.48%

Sector: -40.98% Industry: -40.98%

P/EBITDA

65.17

Sector: -3.75 Industry: -3.75

P/EBIT

139.45

Sector: -3.89 Industry: -3.89

P/ASSET

2.72

Sector: 1.50 Industry: 1.50

BVPS

47.51

Sector: 1.75 Industry: 1.75

EPS

2.43

Sector: -2.03 Industry: -2.03

EQUITY RATIO

0.64

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

-1.94%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-3.34%

Sector: - Industry: -

FAIR VALUE OF Ligand Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 198.22

Fair Value

$ 0.00

Upside Return potential.

-74.29%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LGND

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.79	0.00	0.00%	2.33%	$ 530.32 B	28.46%
PFE	14.84	1.57	10.56%	6.71%	$ 145.82 B	15.65%
ABBV	169.26	-155.52	-91.88%	2.87%	$ 404.20 B	4.00%
NVO	17.95	10.36	57.70%	2.71%	$ 276.68 B	32.78%
MRK	14.20	0.00	0.00%	3.03%	$ 270.23 B	29.63%
AZN	30.68	6.27	20.45%	1.68%	$ 288.33 B	16.17%
BMY	18.42	5.98	32.47%	4.54%	$ 111.27 B	12.57%
GILD	20.83	7.87	37.80%	2.32%	$ 168.96 B	27.88%
ZTS	20.73	10.18	49.11%	1.61%	$ 54.95 B	28.21%
HALO	13.60	16.07	118.17%	0.00%	$ 8.10 B	47.91%
REGN	17.12	2.53	14.79%	0.47%	$ 78.37 B	32.13%
AMGN	26.48	19.28	72.82%	2.76%	$ 185.48 B	19.47%
VRTX	32.63	6.92	21.22%	0.00%	$ 119.91 B	31.35%
MCK	25.22	-175.97	-697.75%	0.37%	$ 101.71 B	1.04%
CAH	31.09	-18.16	-58.40%	0.98%	$ 49.58 B	0.68%
BIIB	15.68	1.39	8.83%	0.00%	$ 25.22 B	15.98%
ADMA	19.09	9.27	48.57%	0.00%	$ 4.00 B	42.87%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

LGND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	04/05/2007	04/19/2007	15,00000000

ABOUT THE COMPANY Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

Average user rating I10

4.0 (0 people)

United States

39 years

Founded: 1987

1995

Time since IPO - 31 years

115

Employees

The Company Ligand Pharmaceuticals Incorporated (United States), is listed on Nasdaq with a market value of $ 4.02 Billions, having an equity of $ 950.17 Millions.

With a total of 115 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 251.23 Millions, which generated a profit in the amount of $ 48.58 Millions.

As for its main indicators, the Company has a P/E ratio of 82.81, a P/BV ratio of 4.23 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker LGND.

Market cap

$ 4.02 Billions

Net worth

$ 950.17 Millions

US$ 950,170,000.00

Assets

$ 1.48 Billion

US$ 1,476,770,000.00

Total Shares Outstanding

20.00 Millions

20,000,000

Average Daily Trading Volume

$ 228.01 Thousand

US$ 228,010.00

Sector

Health Care

Industry

Biotechnology

LGND

LGND revenue and profits

Financial Results LGND

DRAG THE FRAME TO SEE MORE DATA

LGND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 826.62 37,28% (12M)

P/E

25.22

0.37%

ROE

-697.75%

P/BV

-175.97

CAH - Cardinal Health

$ 210.93 63,37% (12M)

P/E

31.09

0.98%

ROE

-58.40%

P/BV

-18.16

JNJ - Johnson & Johnson

$ 221.49 50,20% (12M)

P/E

19.79

2.33%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 107.40 13,78% (12M)

P/E

14.20

3.03%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.88 5,08% (12M)

P/E

14.84

6.71%

ROE

10.56%

P/BV

1.57

ABBV - AbbVie

$ 220.77 30,15% (12M)

P/E

169.26

2.87%

ROE

-91.88%

P/BV

-155.52

AZN - AstraZeneca

$ 94.23 37,33% (12M)

P/E

30.68

1.68%

ROE

20.45%

P/BV

6.27

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 826.62 37,28% (12 M)

P/L

25.22

0.37%

ROE

-697.75%

P/VP

-175.97

CAH - Cardinal Health

$ 210.93 63,37% (12 M)

P/L

31.09

0.98%

ROE

-58.40%

P/VP

-18.16

JNJ - Johnson & Johnson

$ 221.49 50,20% (12 M)

P/L

19.79

2.33%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 107.40 13,78% (12 M)

P/L

14.20

3.03%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.88 5,08% (12 M)

P/L

14.84

6.71%

ROE

10.56%

P/VP

1.57

ABBV - AbbVie

$ 220.77 30,15% (12 M)

P/L

169.26

2.87%

ROE

-91.88%

P/VP

-155.52

AZN - AstraZeneca

$ 94.23 37,33% (12 M)

P/L

30.68

1.68%

ROE

20.45%

P/VP

6.27

Frequently Asked Questions

What is the price of Ligand Pharmaceuticals (LGND) today?

The price of Ligand Pharmaceuticals (LGND) today is $ 198.22, with return of 72.32% compared to the last year. The price of Ligand Pharmaceuticals (LGND) started the year trading around $ 189.07 and today it is at $ 198.22. Follow the real-time price chart, the historical price of Ligand Pharmaceuticals (LGND) and international markets.

When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not distribute dividends in the last year.

Is Ligand Pharmaceuticals (LGND) worth it?

Currently, Ligand Pharmaceuticals (LGND) is priced at $ 198.22, with a P/E of 82.81%, representing a deviation of -9,913% from its historical average P/E. In the last year, the stock showed a variation of 72.32 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 72.32%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Ligand Pharmaceuticals (LGND) stock?

Investing in stocks of Ligand Pharmaceuticals (LGND) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Ligand Pharmaceuticals (LGND) yield today?

The yield of Ligand Pharmaceuticals (LGND) was 1.22% in the last month, 72.32% in the last year and 3.51% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Ligand Pharmaceuticals (LGND) today, the total investment would be $ 19,822.00, based on the current price of $ 198.22.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 34,157.27
In 5 years: $ 20,517.75
In 10 years: $ 38,861.03

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

LGND

Ligand Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of LGND

review the fundamentals of Ligand Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

United States

39 years

1995

115

PROFIT X PRICE LGND

Financial Results LGND

LGND cash flow

asset growth - LGND

LGND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions